Division of Cardiology, University of Chicago, MC 2016, Rm A-621, 5841 S. Maryland Avenue, Chicago, IL, 60637-1470, USA.
Curr Cardiol Rep. 2018 Jan 29;20(1):6. doi: 10.1007/s11886-018-0945-3.
In this paper, we will review developments in the field of durable mechanical circulatory support over the past 3 years.
The role of left ventricular assist device (LVAD) placement in non-inotrope-dependent ambulatory heart failure patients remains controversial in light of recent clinical trials. New devices are on the horizon for destination therapy in advanced heart failure patients. The concept of hemocompatibility and the calculation of hemocompatibility scores represent a novel approach to common adverse events. Recent research in mechanical circulatory support has impacted our approach to durable LVAD therapy and set the stage for further advancements in the field.
本文将对过去 3 年机械循环支持领域的进展进行综述。
鉴于最近的临床试验结果，左心室辅助装置（LVAD）在非正性肌力依赖型活动性心力衰竭患者中的应用作用仍存在争议。新设备即将问世，为晚期心力衰竭患者提供了终末期治疗的选择。血液相容性的概念和血液相容性评分的计算代表了一种处理常见不良事件的新方法。机械循环支持的最新研究改变了我们对耐用型 LVAD 治疗的方法，并为该领域的进一步发展奠定了基础。
